An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
-
- Elshad Hasanov
- Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas
-
- Debra Nana Yeboa
- Department of Radiation Oncology, Division of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas
-
- Mathew D. Tucker
- Department of Medicine, Division of Hematology and Oncology Vanderbilt University Medical Center Nashville Tennessee
-
- Todd A. Swanson
- Department of Radiation Oncology, Division of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas
-
- Thomas Hendrix Beckham
- Department of Radiation Oncology, Division of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas
-
- Brian Rini
- Department of Medicine, Division of Hematology and Oncology Vanderbilt University Medical Center Nashville Tennessee
-
- Chibawanye I. Ene
- Department of Neurosurgery, Division of Surgery The University of Texas MD Anderson Cancer Center Houston Texas
-
- Merve Hasanov
- Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas
-
- Sophie Derks
- Department of Radiology and Nuclear Medicine, Erasmus Medical Center University Medical Center Rotterdam Rotterdam the Netherlands
-
- Marion Smits
- Department of Radiology and Nuclear Medicine, Erasmus Medical Center University Medical Center Rotterdam Rotterdam the Netherlands
-
- Shaan Dudani
- Division of Oncology/Hematology William Osler Health System Brampton Ontario Canada
-
- Daniel Y. C. Heng
- Tom Baker Cancer Center University of Calgary Calgary Alberta Canada
-
- Priscilla K. Brastianos
- Division of Neuro‐Oncology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts
-
- Axel Bex
- The Royal Free London National Health Service Foundation Trust London United Kingdom
-
- Sahin Hanalioglu
- Department of Neurosurgery Hacettepe University Faculty of Medicine Ankara Turkey
-
- Jeffrey S. Weinberg
- Department of Neurosurgery, Division of Surgery The University of Texas MD Anderson Cancer Center Houston Texas
-
- Laure Hirsch
- Department of Medical Oncology Cochin University Hospital, Public Assistance Hospital of Paris Paris France
-
- Maria I. Carlo
- Genitourinary Oncology Service, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York
-
- Ayal Aizer
- Department of Radiation Oncology Brigham and Women's Hospital, Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts
-
- Paul David Brown
- Department of Radiation Oncology Mayo Clinic Rochester Minnesota
-
- Mehmet Asim Bilen
- Department of Hematology and Medical Oncology Emory University School of Medicine Atlanta Georgia
-
- Eric Lin Chang
- Department of Radiation Oncology University of Southern California, Keck School of Medicine California Los Angeles
-
- Jerry Jaboin
- Department of Radiation Medicine Oregon Health & Science University Portland Oregon
-
- James Brugarolas
- Kidney Cancer Program, Simmons Comprehensive Cancer Center The University of Texas Southwestern Medical Center Dallas Texas
-
- Toni K. Choueiri
- Lank Center for Genitourinary Oncology Dana‐Farber Cancer Institute Boston Massachusetts
-
- Michael B. Atkins
- Lombardi Comprehensive Cancer Center MedStar Georgetown University Hospital Washington DC
-
- Bradley A. McGregor
- Lank Center for Genitourinary Oncology Dana‐Farber Cancer Institute Boston Massachusetts
-
- Lia M. Halasz
- Department of Radiation Oncology University of Washington Seattle Washington
-
- Toral R. Patel
- Kidney Cancer Program, Simmons Comprehensive Cancer Center The University of Texas Southwestern Medical Center Dallas Texas
-
- Scott G. Soltys
- Department of Radiation Oncology Stanford Cancer Institute Stanford California
-
- David F. McDermott
- Division of Medical Oncology Beth Israel Deaconess Medical Center Boston Massachusetts
-
- James Bradley Elder
- Department of Neurological Surgery Ohio State University Wexner Medical Center Columbus Ohio
-
- Mustafa K. Baskaya
- Department of Neurological Surgery University of Wisconsin‐Madison, School of Medicine and Public Health Madison Wisconsin
-
- James B. Yu
- Department of Therapeutic Radiology Yale University School of Medicine New Haven Connecticut
-
- Robert Timmerman
- Kidney Cancer Program, Simmons Comprehensive Cancer Center The University of Texas Southwestern Medical Center Dallas Texas
-
- Michelle Miran Kim
- Department of Radiation Oncology University of Michigan Ann Arbor Michigan
-
- Melike Mut
- Department of Neurosurgery Hacettepe University Faculty of Medicine Ankara Turkey
-
- James Markert
- Department of Neurosurgery The University of Alabama at Birmingham Birmingham Alabama
-
- Kathryn Beal
- Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York
-
- Nizar M. Tannir
- Department of Genitourinary Medical Oncology, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas
-
- George Samandouras
- Victor Horsley Department of Neurosurgery The National Hospital for Neurology and Neurosurgery, Queen Square London United Kingdom
-
- Frederick F. Lang
- Department of Neurosurgery, Division of Surgery The University of Texas MD Anderson Cancer Center Houston Texas
-
- Rachel Giles
- International Kidney Cancer Coalition Duivendrecht the Netherlands
-
- Eric Jonasch
- Department of Genitourinary Medical Oncology, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas
書誌事項
- 公開日
- 2022-06-16
- 権利情報
-
- http://creativecommons.org/licenses/by-nc-nd/4.0/
- DOI
-
- 10.3322/caac.21729
- 公開者
- Wiley
この論文をさがす
説明
<jats:title>Abstract</jats:title> <jats:p> Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. <jats:bold>CA Cancer J Clin. 2022;72:454‐489.</jats:bold> </jats:p>
収録刊行物
-
- CA: A Cancer Journal for Clinicians
-
CA: A Cancer Journal for Clinicians 72 (5), 454-489, 2022-06-16
Wiley
